Investor Ideas #Potcasts 614, #Cannabis News and #Stocks on the Move; (TSX: $FAF.TO) (OTCQX: $FFLWF), (TSX: $AVCN.TO) (OTCQX: $AVCNF), (CSE: $LUV.C)
Delta, Kelowna, BC, November 30, 2021 (Investorideas.com Newswire) www.Investoride, as.com, a global news source covering leading sectors including marijuana and hemp stocks and its potcast site, www.potcasts.ca release today’s podcast edition of cannabis news and stocks to watch plus insight from thought leaders and experts.
Listen to the podcast:
https://www.investorideas.com/Audio/Podcasts/2021/113021-StocksToWatch.mp3
Read this in full at https://www.investorideas.com/news/2021/cannabis-potcasts/11301FAF-AVCN-LUV.asp
Hear Investor ideas cannabis potcast on iTunes
Hear the investor ideas potcast on Spotify
Today’s podcast overview/transcript:
Good afternoon and welcome to another episode of Investorideas.com "Potcast" featuring cannabis news, stocks to watch as well as insights from thought leaders and experts.
In today’s podcast we look at a few private and public company announcements.
But first, the big news internationally over the last two weeks has been from Germany as the leaders of Germany’s incoming governing parties announced that they have a formal agreement to legalize marijuana and promote broader drug policy harm reduction measures when they take power.
“We are introducing the controlled supply of cannabis to adults for consumption in licensed stores,” the parties said in a new 118-page agreement, according to a translation. “This controls the quality [of marijuana], prevents the transfer of contaminated substances and guarantees the protection of minors.”
As it stands, personal possession of marijuana is decriminalized in Germany, and there is a medical cannabis program in place. But this proposal seeks to establish a regulated market for adult-use marijuana.
The joint government will review the social impact of legalization four years after implementation.
Beyond cannabis legalization, the so-called traffic light coalition will also advance other drug policy reforms such as establishing drug-checking services where people can have illicit drugs tested for contaminants and other harmful substances without fear of facing criminal sanctions.
The governing coalition—comprised of the Social Democratic Party of Germany (SPD), the Free Democratic Party (FDP) and the Greens—also said that the legislation will restrict advertising for marijuana, alcohol and tobacco products.
Fire & Flower Holdings Corp. (TSX: FAF) (OTCQX: FFLWF), a leading, technology-powered, cannabis retailer announced that, in connection with the potential additional listing of the common shares in the capital of the Company on the Nasdaq, it has filed articles of amendment implementing a consolidation of the Shares on the basis of ten (10) pre-consolidation Shares for every one (1) post-consolidation Share. The Consolidation was previously approved by the Company's shareholders at its annual and special meeting of shareholders held on June 9, 2021.
Trevor Fencott, Chief Executive Officer of Fire & Flower commented, "The share consolidation is an important step in our U.S. expansion strategy. It enables Fire & Flower to qualify for a listing on the NASDAQ and expand its shareholder base which, in turn, provides the Company with increased flexibility and enhanced liquidity to accelerate its strategic growth plans."
"We have built an industry-leading cannabis consumer technology platform and, as demand for our technology platform continues to build in the U.S., now is the right time to advance our NASDAQ listing and make our shares more accessible to a larger investor audience."
"Along with our previously announced acquisitions of trusted cannabis strain information destination, Wikileaf (www.wikileaf.com) and best-in-class dispensary, culture and cannabis marketplace, PotGuide in Denver, Colorado (www.potguide.com), the share consolidation is the next important step in our U.S. expansion strategy. We look forward to completing the listing in the upcoming weeks as we announce continued growth of our cannabis consumer technology platform and execution on our asset-light business model," said Trevor Fencott, CEO of Fire & Flower.
Eco Farm Holdings PBC/ Thrive Society, a technology-forward portfolio of operating assets in cannabis cultivation, manufacturing and consumer brands that is unified through a distribution platform and powered by an upstream digital marketplace, announced that its leading distribution platform, which connects cannabis farmers with buyers across the state of California, now supports over 400 cannabis farmers and 200 buyers including distributors, manufacturers, and retailers. The achieved milestone positions Thrive Society as one of the largest data driven, digitally connected supply chains of legal cannabis in the world.
Operating in California, one of the largest legal cannabis markets in the world with projected sales reaching $7.2 billion in the state by 2024, Thrive Society is a membership-based cannabis distribution platform with a core mission to deliver a more effective farming life cycle and route-to-market by leveraging Agriculture 4.0 technology and focusing on precision agriculture, the internet of things (IoT) and the use of big data to bring greater efficiencies and visibility to its upstream cannabis member-cultivators and downstream member-buyers. Leveraging thousands of data points, Thrive Society empowers farmers to sell cannabis in bulk to buyers with confidence that the market value for their product is competitive – providing a much-needed solution to the marketplace’s existing inconsistent pricing structure. Thrive Society members receive priceless insight into harvesting and demand trends, allowing growers to forecast cultivation strategies in real time. For buyers, Thrive Society offers a real-time marketplace of an extensive library of wholesale cannabis available for sale throughout the state, eliminating stock-out issues and increasing price transparency.
“In every industry, data is king,” said Devin Calloway, co-CEO, Founder and CTO of Eco Farm. “So many operators are flying blind when it comes to harvest planning, price forecasting and inventory management. Our platform, which is fueled by actual transaction metrics that are occurring in real time, offers both sellers and buyers the invaluable information they need to make data-driven operational decisions, mitigate risk and increase profit margins.”
With two showrooms in Los Angeles and Santa Rosa, Thrive Society members are able to list their cannabis products for sale. Showcased products can range from dried flower to concentrates, including product test results, batch information on the product and its availability, and users can post a fair and transparent price, something not seen in most distribution models currently employed throughout the industry. Thrive Society operates under a community membership model where support of mutually beneficial transactions is core to the Company’s ethos.
“Many cannabis businesses still rely on antiquated supply chain systems. Leveraging our years of experience in the cannabis industry, we have built a tech-forward infrastructure model throughout California’s cannabis supply chain that allows us to operate in an efficient and transparent way,” said Danielle Dao, co-CEO and Founder of Eco Farm. “Achieving this milestone of supporting over 600 cannabis operators in the world’s largest cannabis market is a true illustration of the potential national success of our model, which is powered by technology.”
While Thrive Society is one of the largest revenue-generating and innovative segments of the Company, Eco Farm is a portfolio of holdings comprised of operating assets in genetics, cultivation, manufacturing, and consumer brands. Through the Company’s licensed nursery facility and relationships with preferred nursery partners, the Company offers hundreds of genetic varieties of popular cultivars with unparalleled consistency. Genetics remain one of the most important pieces of the cannabis supply chain and leveraging this integrated approach allows Eco Farm to own and control one of the most volatile pieces of the supply chain.
Eco Farm’s highly successful cannabis consumer brand, Lifted Legacy, supports family-owned craft farms in the Emerald Triangle and brings high-quality cannabis cultivars to market. The Lifted Legacy brand is sold in over 75 retail shops throughout California and offers products that are region-specific and chosen through data provided by the Thrive Society platform. Rounding out the vertical integration of Eco Farm is the Company’s highly scalable manufacturing facility, where the Company processes cannabis products for its own brands as well as countless brands sold throughout the state. The entire portfolio is powered by Eco Farm’s world-class technology and plant-touching platforms, including Thrive Society, which is uniquely positioned as a scalable model for emerging markets across the country.
Eco Farm is a public benefit corporation, meaning the Company considers additional stakeholders in its decision-making process besides the traditional economic benefit of its shareholders. Stakeholders could include the community in which the Company operates, the environment as it is impacted by the operations of the business, or its staff and the overall benefit of their involvement in the organization. While this designation adds an additional layer of complexity to the Company’s operations, it was chosen as a way to add tangible metrics to the Company’s mission of driving change through intent and action. The Company is led and staffed by people from all backgrounds and constantly supports social equity programs throughout the industry.
Avicanna Inc. (TSX: AVCN) (OTCQX: AVCNF), a biopharmaceutical company focused on the development, manufacturing, and commercialization of plant-derived cannabinoid-based products, announced that it has entered into a partnership with an established Argentine pharmaceutical company to register and commercialize Avicanna’s proprietary cannabinoid-based pharmaceutical preparations through the licensing of its intellectual property and supply of its active pharmaceutical ingredients (“API”).
Through the partnership Avicanna will provide a non-exclusive license of the Company’s intellectual property related to its proprietary 10% cannabidiol (“CBD”) pharmaceutical drug preparation. Additionally, the partner will source its pharmaceutical-grade CBD exclusively from Avicanna to manufacture the product for the registration and marketing authorization with the Argentine regulatory agency ANMAT.
The marketing authorization of the pharmaceutical preparation is expected to be approved during the second half of 2022 and is expected to be supported with claims related to treatment of epilepsy. The estimated patient population and market potential for epilepsy in Argentina is between 400,000 to 500,000 patients of which about 20,000 patients have refractory epilepsy. “We look forward to entering the Argentine market through a pharmaceutical pathway and to be doing so by delivering our proprietary formulations as solution to patients with unmet medical needs. We are rapidly expanding into the region with innovative and accessible cannabinoid-based pharmaceutical products and are doing so through partnership with reputable industry leaders,” stated Lucas Nosiglia, President of Avicanna LATAM.
Love Pharma Inc. (CSE: LUV) ,a Vancouver, Canada-based company, which operates as a specialized health and wellness company that licenses and distributes psychedelic and cannabis-infused products, has established a practice of offering proven products with clinical data, user studies, and scientific research to support its claims. It’s a practice that gives Love Pharma a distinct market advantage over many of its competitors. And now, Love Pharma is set to broaden that advantage with its recent announcement that the company has signed a Letter of Intent to acquire MicroDoz Therapy, Inc.
The benefit of this acquisition to Love Pharma, its shareholders and worldwide consumers is that the company gains MicroDoz’s exclusive partnership with a world-renowned university to conduct a landmark study into the efficacy of psilocybin assisted treatment of cannabis use disorder. Love Pharma can leverage this relationship to further expand its product lineup, strengthen its clinical validation program, and add to its comprehensive portfolio of intellectual property.
Specifically, the acquisition will further substantiate the company’s efforts to become a frontrunner in the psychedelics and therapeutics space. Love Pharma’s Chief Executive Officer (CEO), Zach Stadnyk, said his company’s existing portfolio, which consists of the exclusive rights to 7 novel therapeutic products focused on mental and sexual wellness, is already at the leading edge of innovation in the industry. So, continued new product development will further build upon what is already a strong foundation. Stadnyk’s goal is to establish a growing and loyal customer base as the company seeks to define the psychedelics and therapeutics industry with solid science that leads to effective products.
When explaining the acquisition of MicroDoz Therapy, the CEO stated, “Science and efficacy are paramount to our strategy, as a result we seized the opportunity to acquire MicroDoz to expedite what will be a landmark study with a world-leading university.”
As an entry point into the burgeoning psychedelics market, the company acquired the rights to the patent-pending psilocybin strip in addition to the acquisition of MicroDoz, which has the exclusive partnership to the landmark study at an unnamed leading global university. Love Pharma announced it expects to release the university’s name along with details of the program when the definitive agreement is close.
Investor ideas reminds all listeners to read our disclaimers and disclosures on the Investorideas.com website and that this podcast is not an endorsement to buy products or services or securities. Investors are reminded all investment involves risk and possible loss of investment.
Learn more about our cannabis podcasts at https://www.investorideas.com/Audio/Potcasts.asp
To hear more Investorideas.com
podcasts visit: https://www.investorideas.com/Audio/.
The Investorideas.com podcasts are also available on iTunes ( Apple Podcasts) , Audible , Spotify, Tunein, Stitcher, Spreaker.com, iHeartRadio , Google Podcasts and most audio platforms available.
Potcasts is now a certified word mark Trademark on the blockchain through Cognate, Inc. CM Certification-Registration Number: 10468217708
About Investorideas.com - News that Inspires Big Investing Ideas
Investorideas.com publishes breaking stock news, third party stock research , guest posts and original articles and podcasts in leading stock sectors. Learn about investing in stocks and get investor ideas in cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable energy, gaming and more. Investor Idea’s original branded content includes podcasts and columns : Crypto Corner , Play by Play sports and stock news , Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast , Cleantech and Climate Change , Exploring Mining , Betting on Gaming Stocks Podcast and the AI Eye Podcast.
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com
Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp
Investor Ideas does not condone the use of cannabis except where permissible by law. Our site does not possess, distribute, or sell cannabis products.
Follow us on Twitter https://twitter.com/Investorideas
Follow us on Facebook https://www.facebook.com/Investorideas
Follow us on YouTube https://www.youtube.com/c/Investorideas
Download our Mobile App for iPhone and Android
Join our Investor Club https://www.investorideas.com/membership/
Contact Investorideas.com
800 665 0411
Get more Cannabis Stock Investor Ideas – news, articles, podcasts and stock directory
